精品毛片一区二区_国产亚洲精品一区二区_久久精品熟一区_1024手机看片你懂得日韩_午夜电影在线观看_日韩精品在线播放视频_国产成人无码AV在线播放动漫_国产又爽又黄免费视频少妇人妻无码精品视频APP_911国产在线_亚洲视频区_中文字幕主播大秀第一页_欧美三级大黄片_日本久久久久亚洲中字幕_国产精品黄片一区_欧美亚洲熟妇一区二区三区 ,国产成人精品高清不卡在线_天天干干天天_精品人伦一区二区三区蜜桃91_人妻与黑人_夜色88v精品国产亚洲av小说_日韩~欧美一中文字幕_中文字幕一区二区在线免费观看中文字幕无线码中文字幕免费_光棍影院一区二区99久久精品一区二区免费_色播亚洲无码视频在线观看_天堂国产+人+综合+亚洲欧美_九七超级碰碰免费视频_国产成人精品自拍_avtt亚洲一区中文字幕_国产精品熟妇一区二区三区四区_亚洲一区二区一卡二卡三区 ,婷婷色中阁一区_国产精品久久久天天影视香蕉_99爱视频精品免视看_免费av一级片_男女做爰猛烈叫床爽爽视频_亚洲成人av影院在线观看_色视频久久_久久婷婷色香五月综合激激情,狠狠做五月人成午夜免费视频无码_成年A片_aA在线射老女_亚洲色鬼中文_亚洲色婷婷av_婷婷在线亚洲_亚洲国产精品夜男人天堂

Poster Authors:

Qiuyuan Yang¹, Kaiqiang Hu¹, Lei Liu^2, Tingting Guo², Haiyan Gu², Pengwei Pan¹, Fang He¹

This poster was presented at AACR 2024.

Methods Applied to Investigate Dabrafenib’s Drug Resistance Mechanism

This research focuses on understanding the BRAF inhibitor resistance mechanism for Dabrafenib, which displays varying efficacy across cancer types. A comprehensive cancer drug resistance mechanism analysis was performed through cancer cell panel screening for Dabrafenib, utilizing the Cell Titer-Glo (CTG) assay. This approach measured Dabrafenib’s potency across hundreds of cell lines, successfully distinguishing resistant and sensitive cell types. Public high-throughput sequencing data was then analyzed using bioinformatics tools to correlate gene expression profiles with Dabrafenib sensitivity. Finally, synergistic drug testing validated the identified resistance mechanism.

Key Findings on BRAF Inhibitor Resistance Mechanism Research

Dabrafenib was highly effective in skin cancer cell lines but demonstrated resistance in myeloid cancer cell lines, emphasizing a distinct BRAF inhibitor resistance mechanism.
Resistance strongly correlated with the upregulation of the PI3K signaling pathway.
Clinical datasets and in vitro experiments confirmed that elevated PIK3CG levels are key contributors to the drug resistance mechanism.
Combining PI3K inhibitors with Dabrafenib successfully reduced resistance, presenting a promising strategy to overcome this drug resistance mechanism in resistant cancer types.

Capabilities

Knowledge Center

Cancer Cell Panel Screening

Cell Biology

Bioinformatics

Connect with a Scientific Expert

Name(Required)

First Last

Company Name(Required)

Job Title(Required)

Country(Required)

State(Required)

Message

Email(Required)

This field is hidden when viewing the form

Lead Source(Required)

By completing and submitting this form, you acknowledge that you have read and understood our Privacy Policy, and you consent to the collection and processing of your personal data by Pharmaron for the purpose of responding to your inquiry. You also agree to be contacted by Pharmaron regarding relevant services and updates. You may withdraw your consent at any time.

Pharmaron’s Specialized Approach to Cancer Drug Resistance Mechanisms

At Pharmaron, we specialize in addressing the challenges of uncovering drug resistance mechanisms through a blend of collaborative strategies and advanced technologies. Our clients work directly with scientists, enabling them to gain tailored, real-time insights into resistance pathways. With a comprehensive service portfolio encompassing bioinformatics, proteomics, genomics, and cell screening assays, Pharmaron provides the expertise and technology to accelerate discoveries. We help our clients to identify resistance mechanisms effectively and pave the way for innovative therapies to overcome cancer drug resistance mechanisms.

Access the full poster by downloading it below.